Abu Dhabi, UAE: Mubadala Bio’s Wellpharma has successfully secured Gulf Health Council (GHC) certification, reinforcing its position as a trusted regional pharmaceutical manufacturer while advancing Mubadala Bio’s goal of strengthening healthcare resilience, and drug security across the region.
As one of the region’s specialized pharmaceutical manufacturers in IV fluids and dialysis solutions, Wellpharma continues to strengthen the UAE’s role in building a more self-reliant and regionally integrated healthcare ecosystem capable of supporting long-term healthcare continuity in the MENA region and beyond.
Issued under the GHC’s unified regulatory framework, the certification follows a rigorous evaluation of Wellpharma’s Good manufacturing standards, quality management systems, product stability protocols, traceability procedures and process control. The assessment covered capabilities across contamination control, sterile production, terminal sterilization of large and small volume liquid injectables, secondary packaging, and quality assurance procedures.
Dr. Essam Mohamed, Chief Executive Officer of Mubadala Bio, said: “This certification reflects the strength of our quality systems, manufacturing standards, and regulatory practices, reinforcing Wellpharma’s position as a trusted pharmaceutical manufacturer serving healthcare providers across the region.”
Hamad Husein Almarzooqi, Deputy Chief Executive Officer of Mubadala Bio, said: “This achievement strengthens our ability to support drug security and expand access to essential medicines across GCC markets, while advancing Abu Dhabi’s role as a regional hub for life sciences and pharmaceutical manufacturing.”
GHC certification supports more streamlined engagement with health authorities across the GCC while strengthening confidence among regulators, partners, and healthcare providers. It also enables more efficient product registration pathways, supports export facilitation, and enhances access to regional procurement programs and healthcare tenders.
As part of Mubadala Bio’s integrated life sciences platform, Abu Dhabi-based Wellpharma is a leading pharmaceutical manufacturer specializing in intravenous (IV) fluids, dialysis solutions, and a broad portfolio of therapeutic products. Operating a fully automated facility equipped with advanced pharmaceutical production technologies, Wellpharma adheres to the highest international quality standards. With an annual production capacity of 11 million bags in a range of forms and sizes, the company plays a vital role in supporting healthcare systems across the UAE and international markets.
